Pacemaker implantation
Pacemaker implantation has been studied in 15 papers since 2015: 14 observational studies in people; 6 in the past year. The newest paper, Oct 26, 2026: “Sex-based differences in baseline characteristics, periprocedural outcomes and long-term survival following transcatheter aortic valve implantation”.
15 papers study it5 findingsUpdated
1 new paper in 30 daysSee all 15 papers on pacemaker implantation
At a glance
The findings reach people, from one lab or study. 4 independent labs in 4 countries.
“whereas pacemaker implantation related to lower risk than AVB/SND without pacing.”
None of its findings points the other way.
- 4 independent labs in 4 countries
- Funder: The University of Western Australia
- Humans14
What did studies of pacemaker implantation find?
1Studies of pacemaker implantation measured one outcome, residential aged care facility admission.
Residential aged care facility admission
no changein humans1HR 1
1 study
Residential aged care facility admission
no changein humans1HR 1
Pacemaker implantation was not clearly linked with residential aged care facility admission in humans (HR 1.00 [0.96-1.04], p = 0.92).
Humans
What is pacemaker implantation linked with?
4Studies link pacemaker implantation with 4 measures, among them mortality, dementia and syncope.
Mortality
upin humans1HR 1.03
1 study
Mortality
upin humans1HR 1.03
Pacemaker implantation is associated with mortality in humans (HR 1.03 [1.00-1.05], p = 0.027).
Humans
Dementia
downin humans1
1 study
Dementia
downin humans1
Pacemaker implantation is linked with a lower risk of dementia in AVB/SND patients.
Humansin AVB/SND patients
Syncope
upin humans1RR 2.01
1 study
Syncope
upin humans1RR 2.01
Syncope is linked with a higher risk of pacemaker implantation in humans (patients with femur fracture) (RR 2.01, 95% CI 1.55-2.46).
Humanspatients with femur fracturen = 93,093
1-year mortality
upin humans1HR 6.87
1 study
1-year mortality
upin humans1HR 6.87
Pacemaker implantation is associated with 1-year mortality in humans (severe aortic stenosis after transcatheter aortic valve replacement) (HR 6.87, 95% CI 2.32–20.3).
Humanssevere aortic stenosis after transcatheter aortic valve replacement1 yearn = 107